TAVR in cancer; healing the sickest of the sick

Abstract

Transcatheter aortic valve replacement (TAVR) procedure became a standard treatment for symptomatic severe aortic stenosis in high-risk patients for open heart surgery. • The TAVR short-term and long-term mortality rates are similar between cancer survivors and patients without cancer.